-
Validation of a One-Page Impulse Control Disorder Questionnaire in a Parkinson’s Disease Clinic
-
Validation of a patient/caregiver questionnaire to evaluate nocturnal hypokinesia in Parkinson’s disease
-
Validation of protein phosphatases that regulate the LRRK2 phosphorylation cycle
-
Validation of the French version of the Munich Dysphagia Test-Parkinson’s disease (MDT-PD) in a multilingual population of the Luxembourg Parkinson’s Study (HELP-PD)
-
Validation of the Hong Kong Chinese version of NMSQuest (HK-NMSQ)
-
Validation of the new diagnostic criteria for fatigue in Parkinson’s disease
-
Validation of the Parkinson’s Disease Pain Symptoms Scale (PD-PSS): An interim report
-
Validity And Reliability Of Nineteen-Item Wearing-Off Questionnaire In Turkish Patients
-
Variable selection using machine-learning to identify new signatures of patient-derived aggregated α-synuclein-induced neurodegeneration in non-human primates
-
Variants in MCCC1/LAMP3 and DGKQ Identified Through GWAS are Not Associated with PD in a Malaysian Malay Cohort
-
Variation in the L-dopa motor response in pathologically confirmed Parkinson’s disease
-
Vascular parkinsonism: Clinical features and comparison with Parkinson’s disease
-
Vascular risk factors prevalence differences between Vascular Parkinsonism (VaP) and Parkinson Disease (PD) in a hospital cross-section study
-
Vertical and horizontal eye movements in a large cohort of early manifest Huntington’s disease: Evidence from ENROLL-HD
-
Vestibulo-Ocular Reflex Assessment in Patients with Sporadic Ataxia
-
Visual cueing using laser-shoes reduces freezing of gait in Parkinson patients at home
-
Visual deficits of self-motion perception in Parkinson’s disease
-
Visual hallucinations and autonomic burden are inversely associated with physical activity in PD
-
Visual impairment and falls in Parkinson’s disease (PD)
-
VIT-D and Tics Movement Disorder
-
Vitamin B3 and Neurodevelopment in Parkinson’s Disease
-
Voluntary suppression of Parkinson’s tremor
-
Vowel characteristics associated with Parkinson’s disease in Cantonese
-
VY-AADC01 gene therapy in Parkinson’s disease: Interim results of the on-going Phase 1b PD-1101 trial
2018 International Congress
October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.